R-209

N/A

Report date: 2025/06/11 10:35:14
NME

Base Information

Drug NameR-209
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 inhibitorsInterleukin-1 receptor-associated kinase 1 antagonists
TargetsInterleukin-1 receptor-associated kinase 4Interleukin-1 receptor-associated kinase 1
Therapy Area/IndicationsSkin Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRigel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRigel Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSkin Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A